Searched for
SHASHUN
Carlyle Group portfolio companies in advanced talks for a potential mergerSequent Scientific, which is in animal health business, posted revenue of around Rs 1,400 crore in FY24. It had earnings before interest, t...- SBI’s NPA cycle has peaked out, better days expectedG.Chokkalingam, Founder, Equinomics Research & Advisory, answers all your stock queries.
- 10 largecaps ruined your money even as BSE m-cap scaled Mt. 150 lakh cr markData showed shares of Lupin have tumbled over 41 per cent this year.
- Pharma stocks slump up to 5% on investigation by US' DoJIPCA Labs dropped 4.15 per cent to Rs 560.35. Strides Shashun, Dr Reddy’s Labs and Aurobindo Pharma shed 3.99 per cent, 3.88 per cent and 3...
- Mapping the market: Metals, smallcaps hog limelight in true Dhanteras traditionWithout waiting for the auspicious one-hour Muhurat trading, let us figure out which stocks made money for investors on a day when gold rul...
- QIP issue a harbinger for good times for a stock? Think again!The performance of stocks post QIPs has not been that great, a study by ETMarkets.com based on issues placed between January 2015 and Augus...
- Double-digit topline growth in Q1, but m-caps down by one-third! Are these stocks good buys?Data available with corporate database Capitaline showed these stocks belong to pharma, textiles and IT packs and also include a few credit...
- Strides Shashun tanks 3% as brokers cut target price post weak Q1Taking its fall to the fourth consecutive trading session, the stock fell 3.4 per cent to hit a low of Rs 1,023 on BSE.
- Mapping the market: Sensex, Nifty on a high to erase bad memories of freaky FridayThis day last week, there was bloodbath on Dalal Street after the Brits voted to part ways with the European Union. You won’t even see trac...
- FY16 review: India Inc raised Rs 48,952 cr via equity offerings; IPOs saw fivefold jumpMaking a smart comeback, the primary market clocked 25 issuances that mopped up Rs 14,772 crore in what could be called the best FY for IPO...
- Strides Shashun slides after announcing two acquisitionsShares of Strides Shashun dropped over 2 per cent in Tuesday's trade after the drugmaker said it had acquired controlling stakes in Kenya's...
- Strides Arcolab changes name to Strides Shasun LtdIn September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
- Strides Arcolab to approach Foreign Investment Promotion Board for its caseShares of Strides Arcolab were trading at Rs 1,172.55 per scrip on BSE post afternoon trade, up 0.36 per cent share from their previous clo...
- CCI gives green signal to merger of Shasun Pharma with StridesThe combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 1...
- Shasun Pharmaceuticals seeks shareholder nod for merger with Strides ArcolabIn a filing to the BSE, Shasun Pharmaceuticals said it is seeking shareholders nod for the merger scheme through a postal ballot.
- Strides Arcolab shares gain 9% on merger with Shasun PharmaShares of Strides Arcolab gained over 9 per cent today after the company and Shasun Pharmaceuticals announced their merger .
- Strides, Shasun announce merger; to create Rs 2,500 crore entityBased on the exchange ratio, Shasun shareholders will own 26 per cent of the combined entity.
- Shasun Pharmaceuticals acquires global rights for Ibuprofen from ScolorPharmaShashun is among top vertically integrated manufacturers of Ibuprofen and its derivatives, from actives to formulated packaged products.
- Dealing Room: HDIL, Shasun Pharma, PGC, REC, L&TET Now spoke to dealers on institutional and high net worth investors’ activity in the dealing room. The following stocks were on their rad...
- Dealing Room Buzz: Shashun Pharma, Titan, Bombay DyeingET Now spoke to dealers on institutional and high net worth investors' activity in the dealing room. The following stocks were on their rad...
Load More
